News & Updates

Show Multimedia Only

Hepatic steatosis increases non-calcified plaque burden

08 Jul 2026

Hepatic steatosis may raise the risk of major adverse cardiovascular events through increased non-calcified plaque burden, according to a study.

Hepatic steatosis increases non-calcified plaque burden

08 Jul 2026

Dysphagia a red flag for poor outcomes after cardiovascular procedures

08 Jul 2026 by

Among individuals undergoing common cardiovascular procedures, those with a preoperative diagnosis of dysphagia face an increased risk of postoperative mortality and complications, according to a retrospective study.

Dysphagia a red flag for poor outcomes after cardiovascular procedures

08 Jul 2026

COPD exacerbations up risk of cardiopulmonary complications

05 Jul 2026

In patients with chronic obstructive pulmonary disease (COPD), acute exacerbations contribute to an increased risk of cardiopulmonary complications, as shown in a retrospective cohort study.

COPD exacerbations up risk of cardiopulmonary complications

05 Jul 2026

Cardiac rehab equally effective post-COVID

04 Jul 2026 by

Cardiac rehabilitation produces functional capacity gains and quality of life improvements in patients with coronary heart disease (CHD), and a history of COVID-19 does not blunt this effect, according to a study.

Cardiac rehab equally effective post-COVID

04 Jul 2026

Novel oral small-molecule PCSK9 inhibitor shows promise in hypercholesterolemia

04 Jul 2026

In the treatment of hypercholesterolemia, the investigational oral small-molecule PCSK9 inhibitor laroprovstat appears well tolerated and may help reduce low-density lipoprotein cholesterol (LDL-C) levels when used in combination with rosuvastatin, according to a phase I study.

Novel oral small-molecule PCSK9 inhibitor shows promise in hypercholesterolemia

04 Jul 2026

CCB outperforms beta-blocker for managing hypertension in HFpEF

03 Jul 2026 by

The oral dihydropyridine calcium channel blocker (CCB) amlodipine appears more beneficial than the beta-blocker metoprolol for managing hypertension in patients with heart failure with preserved ejection fraction (HFpEF), with greater effects on blood pressure (BP) control and exercise capacity, as shown in a randomized crossover trial.

CCB outperforms beta-blocker for managing hypertension in HFpEF

03 Jul 2026

Wearables, smartphones promote physical activity among CVD patients

02 Jul 2026

Among patients with cardiovascular disease (CVD), the use of smartphones and wearable devices leads to substantial gains in daily steps and minutes spent in moderate-to-vigorous physical activity, according to a systematic review and meta-analysis.

Wearables, smartphones promote physical activity among CVD patients

02 Jul 2026

Exercise performance in obstructive HCM better with aficamten vs metoprolol

01 Jul 2026

In the treatment of patients with obstructive hypertrophic cardiomyopathy (HCM), aficamten exerts superior effects on a broad array of exercise measures compared with metoprolol, according to a secondary analysis of the phase III MAPLE-HCM trial.

Exercise performance in obstructive HCM better with aficamten vs metoprolol

01 Jul 2026

Gout predisposes AF patients to ischaemic stroke

30 Jun 2026 by

Gout may increase susceptibility of atrial fibrillation (AF) patients to ischaemic stroke, according to new research.

Gout predisposes AF patients to ischaemic stroke

30 Jun 2026

SGLT2i helps prevent cardiovascular events in diabetes patients with acute MI

30 Jun 2026

Early treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with a lower cardiovascular risk among diabetes patients with acute myocardial infarction (MI), reports a study.

SGLT2i helps prevent cardiovascular events in diabetes patients with acute MI

30 Jun 2026

News & Updates

Showing Cardiology articles

Showing

Specialty:

Hepatic steatosis increases non-calcified plaque burden

Hepatic steatosis increases non-calcified plaque burden

Dysphagia a red flag for poor outcomes after cardiovascular procedures

Dysphagia a red flag for poor outcomes after cardiovascular procedures

COPD exacerbations up risk of cardiopulmonary complications

COPD exacerbations up risk of cardiopulmonary complications

Cardiac rehab equally effective post-COVID

Cardiac rehab equally effective post-COVID

Novel oral small-molecule PCSK9 inhibitor shows promise in hypercholesterolemia

Novel oral small-molecule PCSK9 inhibitor shows promise in hypercholesterolemia

CCB outperforms beta-blocker for managing hypertension in HFpEF

CCB outperforms beta-blocker for managing hypertension in HFpEF

Wearables, smartphones promote physical activity among CVD patients

Wearables, smartphones promote physical activity among CVD patients

Exercise performance in obstructive HCM better with aficamten vs metoprolol

Exercise performance in obstructive HCM better with aficamten vs metoprolol

Gout predisposes AF patients to ischaemic stroke

Gout predisposes AF patients to ischaemic stroke

SGLT2i helps prevent cardiovascular events in diabetes patients with acute MI

SGLT2i helps prevent cardiovascular events in diabetes patients with acute MI